[
  {
    "ts": "2025-12-14T08:30:00+00:00",
    "headline": "Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock.",
    "summary": "A secretive biotechnology-centered hedge fund bought shares of  Kymera Therapeutics  after the stock soared to its highest level on record.  A Form 4 filed with the Securities and Exchange Commission on Dec. 11 shows Baker Brothers Advisors bought just over 2 million shares of the biopharmaceutical company for roughly $172 million in two separate transactions that day.  Shares pulled back slightly from those levels before Baker Bros. swooped in on Thursday.",
    "url": "https://www.barrons.com/articles/kymera-stock-price-baker-brothers-0b0511b4?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "bca352af-8e04-33c4-ac8d-a53dbe076f54",
      "content": {
        "id": "bca352af-8e04-33c4-ac8d-a53dbe076f54",
        "contentType": "STORY",
        "title": "Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock.",
        "description": "",
        "summary": "A secretive biotechnology-centered hedge fund bought shares of  Kymera Therapeutics  after the stock soared to its highest level on record.  A Form 4 filed with the Securities and Exchange Commission on Dec. 11 shows Baker Brothers Advisors bought just over 2 million shares of the biopharmaceutical company for roughly $172 million in two separate transactions that day.  Shares pulled back slightly from those levels before Baker Bros. swooped in on Thursday.",
        "pubDate": "2025-12-14T08:30:00Z",
        "displayTime": "2025-12-14T08:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/bca352af-8e04-33c4-ac8d-a53dbe076f54/kymera-had-a-big-week-this.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/abda15d9679a611e63143b31df3b2e69",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lwkHDC2HlXtK9K6zYoqPJQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/abda15d9679a611e63143b31df3b2e69.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LNkRLUytE_Nd3U0Nvzk93A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/abda15d9679a611e63143b31df3b2e69.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/kymera-stock-price-baker-brothers-0b0511b4?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KYMR"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "BEIGF"
            },
            {
              "symbol": "ONC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]